Close Menu
NEW YORK (GenomeWeb News) – Gene synthesis firm Geneart said Friday that it planned to issue bonus shares in a 1:1 ratio in order to double its number of tradable shares. 
 
Geneart, based in Regensburg, Germany, is listed on the German Stock Exchange.
 
The company said that the issue of bonus shares is comparable to a 1:1 stock split. It doubles the number of shares for each account, while the price of each share is halved.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.